PROCEPT BioRobotics Corpo... (PRCT)
Statistics
Share Statistics
PROCEPT BioRobotics has 56.92M shares outstanding. The shares have a market value of 1.25B.
| 56.92M | |
| 6.56% | |
| 0.98% | |
| 107.02% | |
| 54.23M | |
| 26,164 | |
| n/a |
Short Selling Information
Short interest in PROCEPT BioRobotics is 12.38% of the outstanding shares, representing 7.09M shares. The short ratio is 4.76.
| 7.09M | |
| 12.38% | |
| 12.74% | |
| 4.76 |
Enterprise Valuation
The enterprise value is 1.11B. Enterprise value adds debt and subtracts cash from the company's market cap, providing an alternative valuation for the company.
| 3.28 | |
| -10.33 | |
| -14.89 | |
| -13.03 |
Financial Position
PROCEPT BioRobotics's current ratio is 6.55. A current ratio above 1 means that the company has enough short-term assets to cover its short-term liabilities.
| 6.55 | |
| 5.23 | |
| 0.23 | |
| -0.78 | |
| -0.91 | |
| -30.53 |
Financial Efficiency
Return on Equity is -30.24%, and return on invested capital is -25.39%.
| -30.24% | |
| -14.39% | |
| -25.39% | |
| $379.89K | |
| $-123.6K | |
| 888 | |
| 0.7 | |
| 1.57 |
Taxes
| n/a | |
| n/a |
Stock Price Statistics
The stock price has increased by -47.03% in the past year.
| 0.89 | |
| -47.03% | |
| 21.49 | |
| 26.98 | |
| 77.34 | |
| 1,682,914 |
Income Statement
In the last 12 months, PROCEPT BioRobotics had revenue of 337.34M and earned -109.75M in profits. Earnings per share was -2.02.
| 337.34M | |
| 216.65M | |
| -114.23M | |
| -109.75M | |
| -98.99M | |
| -106.04M | |
| -2.02 |
Balance Sheet
PROCEPT BioRobotics has 227.91M in cash on the balance sheet. Total assets are 479.35M, and total liabilities are 77.5M.
| 227.91M | |
| 77.5M | |
| 150.41M | |
| -700.06M | |
| 479.35M | |
| 356.09M |
Cash Flow
PROCEPT BioRobotics's operating cash flow was -74.34M over the trailing twelve months.
| -74.34M | |
| -10.59M | |
| -84.92M | |
| -1.492 |
Margins
PROCEPT BioRobotics's gross profit margin was 64.22%, while its operating and net profit margins were -33.86% and -32.54%, respectively.
| 64.22% | |
| -33.86% | |
| -32.46% | |
| -32.54% | |
| -29.34% | |
| -31.43% | |
| -25.17% |
Analyst Forecast
According to 11 stock analysts, the average 12-month price target for PROCEPT BioRobotics is $21. The average analyst rating is "Hold".
| $21 | |
| -4.33% | |
| Hold | |
| 11 |
Fair Value
There are several formulas that can be used to estimate the fair value of a stock, including the Graham Number and Lynch Fair Value methods.
| n/a | |
| n/a | |
| n/a | |
| n/a |
Scores
| 4.2 | |
| 3 |